```json
{
"content": [
{
"type": "paragraph",
"content": "Digital Breast Tomosynthesis (DBT) Equipment segmentation by application reveals distinct clinical drivers within the market. The primary subtypes are screening and diagnostic imaging. Screening applications, accounting for ~60% of the market, focus on early cancer detection in asymptomatic populations, driven by rising breast cancer prevalence and government-led screening programs. Diagnostic imaging, representing ~40%, addresses cases requiring further evaluation of abnormalities detected during screening. This dual application structure underscores the market’s reliance on proactive healthcare strategies and the need for precision diagnostics, with screening dominating due to its role in preventive care, while diagnostic imaging sustains demand through specialized workflows and higher procedural volumes."
},
{
"type": "paragraph",
"content": "The Digital Breast Tomosynthesis (DBT) Equipment market is further categorized by types into standalone systems and integrated systems. Standalone systems, constituting ~70% of the market, are dedicated DBT units offering high-resolution imaging and streamlined workflows, favored in high-volume screening centers. Integrated systems, comprising ~30%, combine DBT with 2D mammography or other modalities, appealing to facilities prioritizing space efficiency and cost-sharing. The dominance of standalone systems reflects their accuracy and adaptability to evolving clinical protocols, whereas integrated systems cater to niche markets seeking multi-functional solutions. This taxonomy highlights the balance between specialized and hybrid technologies in shaping market dynamics."
}
],
"chartData": {
"segments": [
{ "name": "Screening", "value": 60 },
{ "name": "Diagnostic Imaging", "value": 40 }
]
}
}
```
